Gender differences in the subjective effects of MDMA
Matthias E. Liechti, Alex Gamma, Franz X. Vollenweider
Psychopharmacology March 5, 2001 DOI: 10.1007/s002130000648 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Pooled analysis of three double-blind placebo-controlled studies Peer reviewed |
|---|---|
| Sample size | 74 |
| Population | Healthy volunteers with no or minimal MDMA experience |
| Intervention | MDMA |
| Dose | 70-150 mg (1.35-1.8 mg/kg) |
| Duration | Experimental session and 24-hour follow-up |
| Topics | Anxiety MDMA Serotonin |
| Keywords | Heart rate Placebo Mood Adverse effect Blood pressure |
| Citations | 357 |
| Key points | Women experienced more intense subjective psychoactive effects and more adverse effects from MDMA than men, while men had greater blood pressure increases. |
Abstract
Rationale3.4-Methylenedioxymethamphetamine (MDMA) mainly releases serotonin (5-HT) and is contained in the recreational drug Ecstasy. 5-HT is known to play an important role in mood and anxiety disorders, for which there is a female preponderance. To date, there are no systematic data on gender differences in the subjective effects of MDMA.ObjectivesThe present work analyzed the pooled data from three controlled studies on the psychological and physiological effects of MDMA in healthy volunteers with no or minimal MDMA experience. A particular focus of the analyses were possible gender differences.MethodsA total of 74 subjects (54 male, 20 female) participated in all three studies. MDMA in oral doses ranging from 70-150 mg (1.35-1.8 mg/kg) was administered under double-blind placebo-controlled conditions. Subjective peak changes were assessed by standardized psychometric rating scales. Physiological measures were blood pressure, heart rate, and peripheral body temperature. Adverse drug effects were assessed during the experimental session and after 24 h.ResultsPsychoactive effects of MDMA were more intense in women than in men. Women especially had higher scores for MDMA-induced perceptual changes, thought disturbances, and fear of loss of body control. The dose of MDMA positively correlated with the intensity of perceptual changes in women. Acute adverse effects and sequelae were also more frequent in female than in male subjects. In contrast, men showed higher increases in blood pressure than woman.ConclusionsThe fact that equal doses of MDMA per kilogram body weight produce stronger responses in women compared to men is consistent with an increased susceptibility of women to the 5-HT-releasing effects of MDMA. Our results also indicate that increasing doses of MDMA produce more hallucinogen-like perceptual alterations, particularly in women.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Women reported more intense psychoactive effects, including thought disturbances and fear of loss of body control, and more acute adverse effects than men, while men showed greater blood pressure increases.
Synthesized
Comparable studies
Other randomized controlled trials on MDMA for anxiety, most cited first.
Citations in the library
Cited by 192
- Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV) PLoS One August 31, 2010
- The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology July 19, 2010
- Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects Biological Psychiatry November 29, 2014
- A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) Journal of Psychopharmacology October 31, 2012
- Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. Journal of Psychopharmacology 2013
and 187 more in the library
Cites 25
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport December 1, 1998
- Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings The Lancet October 1, 1998
- Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences December 17, 1984
- The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans Pharmacopsychiatry July 1, 1998
- Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens Journal of Psychoactive Drugs October 1, 1986
and 20 more in the library